180 related articles for article (PubMed ID: 37589970)
1. Systemic Anticancer Therapy and Thromboembolic Outcomes in Hospitalized Patients With Cancer and COVID-19.
Gulati S; Hsu CY; Shah S; Shah PK; Zon R; Alsamarai S; Awosika J; El-Bakouny Z; Bashir B; Beeghly A; Berg S; de-la-Rosa-Martinez D; Doroshow DB; Egan PC; Fein J; Flora DB; Friese CR; Fromowitz A; Griffiths EA; Hwang C; Jani C; Joshi M; Khan H; Klein EJ; Heater NK; Koshkin VS; Kwon DH; Labaki C; Latif T; McKay RR; Nagaraj G; Nakasone ES; Nonato T; Polimera HV; Puc M; Razavi P; Ruiz-Garcia E; Saliby RM; Shastri A; Singh SRK; Tagalakis V; Vilar-Compte D; Weissmann LB; Wilkins CR; Wise-Draper TM; Wotman MT; Yoon JJ; Mishra S; Grivas P; Shyr Y; Warner JL; Connors JM; Shah DP; Rosovsky RP;
JAMA Oncol; 2023 Oct; 9(10):1390-1400. PubMed ID: 37589970
[TBL] [Abstract][Full Text] [Related]
2. Trends in Venous Thromboembolism Anticoagulation in Patients Hospitalized With COVID-19.
Vaughn VM; Yost M; Abshire C; Flanders SA; Paje D; Grant P; Kaatz S; Kim T; Barnes GD
JAMA Netw Open; 2021 Jun; 4(6):e2111788. PubMed ID: 34115129
[TBL] [Abstract][Full Text] [Related]
3. The CoVID-TE risk assessment model for venous thromboembolism in hospitalized patients with cancer and COVID-19.
Li A; Kuderer NM; Hsu CY; Shyr Y; Warner JL; Shah DP; Kumar V; Shah S; Kulkarni AA; Fu J; Gulati S; Zon RL; Li M; Desai A; Egan PC; Bakouny Z; Kc D; Hwang C; Akpan IJ; McKay RR; Girard J; Schmidt AL; Halmos B; Thompson MA; Patel JM; Pennell NA; Peters S; Elshoury A; de Lima Lopes G; Stover DG; Grivas P; Rini BI; Painter CA; Mishra S; Connors JM; Lyman GH; Rosovsky RP;
J Thromb Haemost; 2021 Oct; 19(10):2522-2532. PubMed ID: 34260813
[TBL] [Abstract][Full Text] [Related]
4. Venous Thromboembolism After COVID-19 Infection Among People With and Without Immune-Mediated Inflammatory Diseases.
Khan R; Kuenzig ME; Tang F; Im JHB; Widdifield J; McCurdy JD; Kaplan GG; Benchimol EI
JAMA Netw Open; 2023 Oct; 6(10):e2337020. PubMed ID: 37812417
[TBL] [Abstract][Full Text] [Related]
5. Interplay of Immunosuppression and Immunotherapy Among Patients With Cancer and COVID-19.
Bakouny Z; Labaki C; Grover P; Awosika J; Gulati S; Hsu CY; Alimohamed SI; Bashir B; Berg S; Bilen MA; Bowles D; Castellano C; Desai A; Elkrief A; Eton OE; Fecher LA; Flora D; Galsky MD; Gatti-Mays ME; Gesenhues A; Glover MJ; Gopalakrishnan D; Gupta S; Halfdanarson TR; Hayes-Lattin B; Hendawi M; Hsu E; Hwang C; Jandarov R; Jani C; Johnson DB; Joshi M; Khan H; Khan SA; Knox N; Koshkin VS; Kulkarni AA; Kwon DH; Matar S; McKay RR; Mishra S; Moria FA; Nizam A; Nock NL; Nonato TK; Panasci J; Pomerantz L; Portuguese AJ; Provenzano D; Puc M; Rao YJ; Rhodes TD; Riely GJ; Ripp JJ; Rivera AV; Ruiz-Garcia E; Schmidt AL; Schoenfeld AJ; Schwartz GK; Shah SA; Shaya J; Subbiah S; Tachiki LM; Tucker MD; Valdez-Reyes M; Weissmann LB; Wotman MT; Wulff-Burchfield EM; Xie Z; Yang YJ; Thompson MA; Shah DP; Warner JL; Shyr Y; Choueiri TK; Wise-Draper TM;
JAMA Oncol; 2023 Jan; 9(1):128-134. PubMed ID: 36326731
[TBL] [Abstract][Full Text] [Related]
6. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry.
Giannis D; Allen SL; Tsang J; Flint S; Pinhasov T; Williams S; Tan G; Thakur R; Leung C; Snyder M; Bhatia C; Garrett D; Cotte C; Isaacs S; Gugerty E; Davidson A; Marder GS; Schnitzer A; Goldberg B; McGinn T; Davidson KW; Barish MA; Qiu M; Zhang M; Goldin M; Matsagkas M; Arnaoutoglou E; Spyropoulos AC
Blood; 2021 May; 137(20):2838-2847. PubMed ID: 33824972
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Spyropoulos AC; Goldin M; Giannis D; Diab W; Wang J; Khanijo S; Mignatti A; Gianos E; Cohen M; Sharifova G; Lund JM; Tafur A; Lewis PA; Cohoon KP; Rahman H; Sison CP; Lesser ML; Ochani K; Agrawal N; Hsia J; Anderson VE; Bonaca M; Halperin JL; Weitz JI;
JAMA Intern Med; 2021 Dec; 181(12):1612-1620. PubMed ID: 34617959
[TBL] [Abstract][Full Text] [Related]
8. Incidence and mortality due to thromboembolic events during the COVID-19 pandemic: Multi-sourced population-based health records cohort study.
Aktaa S; Wu J; Nadarajah R; Rashid M; de Belder M; Deanfield J; Mamas MA; Gale CP
Thromb Res; 2021 Jun; 202():17-23. PubMed ID: 33711754
[TBL] [Abstract][Full Text] [Related]
9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
10. Epidemiology of Cancer-Associated Venous Thromboembolism in Patients With Solid and Hematologic Neoplasms in the Veterans Affairs Health Care System.
Martens KL; Li A; La J; May SB; Swinnerton KN; Tosi H; Elbers DC; Do NV; Brophy MT; Gaziano JM; Lotfollahzadeh S; Chitalia V; Ravid K; Fillmore NR
JAMA Netw Open; 2023 Jun; 6(6):e2317945. PubMed ID: 37306999
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
12. Incidence of venous thromboembolism in hospitalized patients with COVID-19.
Middeldorp S; Coppens M; van Haaps TF; Foppen M; Vlaar AP; Müller MCA; Bouman CCS; Beenen LFM; Kootte RS; Heijmans J; Smits LP; Bonta PI; van Es N
J Thromb Haemost; 2020 Aug; 18(8):1995-2002. PubMed ID: 32369666
[TBL] [Abstract][Full Text] [Related]
13. Interventions for implementation of thromboprophylaxis in hospitalized patients at risk for venous thromboembolism.
Kahn SR; Morrison DR; Diendéré G; Piché A; Filion KB; Klil-Drori AJ; Douketis JD; Emed J; Roussin A; Tagalakis V; Morris M; Geerts W
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD008201. PubMed ID: 29687454
[TBL] [Abstract][Full Text] [Related]
14. Incidence and clinical profile of venous thromboembolism in hospitalized COVID-19 patients from Madrid region.
Arribalzaga K; Martínez-Alfonzo I; Díaz-Aizpún C; Gutiérrez-Jomarrón I; Rodríguez M; Castro Quismondo N; Pérez-Fernández E; Velasco-Rodríguez D; Gómez E; Fernández B; Vilches A; Martín-Herrero S; Castilla L; Blanco MJ; Gutiérrez MDM; Rivas I; Pascual C; Rosado B; Sola E; Vidal-Laso R; Asenjo S; Mora Casado MA; Benito-Parra L; Carmona I; Marín K; Acedo N; García-León N; Marcheco A; Guillén C; Fernández C; Rodríguez R; Pardo L; Silva P; Montero L; Meijón M; Massó P; Llamas-Sillero P;
Thromb Res; 2021 Jul; 203():93-100. PubMed ID: 33989984
[TBL] [Abstract][Full Text] [Related]
15. Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.
Rutjes AW; Porreca E; Candeloro M; Valeriani E; Di Nisio M
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD008500. PubMed ID: 33337539
[TBL] [Abstract][Full Text] [Related]
16. Variation in Clinical Treatment and Outcomes by Race Among US Veterans Hospitalized With COVID-19.
Castro AD; Mayr FB; Talisa VB; Shaikh OS; Omer SB; Yende S; Butt AA
JAMA Netw Open; 2022 Oct; 5(10):e2238507. PubMed ID: 36282499
[TBL] [Abstract][Full Text] [Related]
17. Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium.
Grivas P; Khaki AR; Wise-Draper TM; French B; Hennessy C; Hsu CY; Shyr Y; Li X; Choueiri TK; Painter CA; Peters S; Rini BI; Thompson MA; Mishra S; Rivera DR; Acoba JD; Abidi MZ; Bakouny Z; Bashir B; Bekaii-Saab T; Berg S; Bernicker EH; Bilen MA; Bindal P; Bishnoi R; Bouganim N; Bowles DW; Cabal A; Caimi PF; Chism DD; Crowell J; Curran C; Desai A; Dixon B; Doroshow DB; Durbin EB; Elkrief A; Farmakiotis D; Fazio A; Fecher LA; Flora DB; Friese CR; Fu J; Gadgeel SM; Galsky MD; Gill DM; Glover MJ; Goyal S; Grover P; Gulati S; Gupta S; Halabi S; Halfdanarson TR; Halmos B; Hausrath DJ; Hawley JE; Hsu E; Huynh-Le M; Hwang C; Jani C; Jayaraj A; Johnson DB; Kasi A; Khan H; Koshkin VS; Kuderer NM; Kwon DH; Lammers PE; Li A; Loaiza-Bonilla A; Low CA; Lustberg MB; Lyman GH; McKay RR; McNair C; Menon H; Mesa RA; Mico V; Mundt D; Nagaraj G; Nakasone ES; Nakayama J; Nizam A; Nock NL; Park C; Patel JM; Patel KG; Peddi P; Pennell NA; Piper-Vallillo AJ; Puc M; Ravindranathan D; Reeves ME; Reuben DY; Rosenstein L; Rosovsky RP; Rubinstein SM; Salazar M; Schmidt AL; Schwartz GK; Shah MR; Shah SA; Shah C; Shaya JA; Singh SRK; Smits M; Stockerl-Goldstein KE; Stover DG; Streckfuss M; Subbiah S; Tachiki L; Tadesse E; Thakkar A; Tucker MD; Verma AK; Vinh DC; Weiss M; Wu JT; Wulff-Burchfield E; Xie Z; Yu PP; Zhang T; Zhou AY; Zhu H; Zubiri L; Shah DP; Warner JL; Lopes G
Ann Oncol; 2021 Jun; 32(6):787-800. PubMed ID: 33746047
[TBL] [Abstract][Full Text] [Related]
18. Thromboembolic events associated with immune checkpoint inhibitors: A real-world study of data from the food and drug administration adverse event reporting system (FAERS) database.
Li H; Sun X; Sun D; Zhao J; Xu Z; Zhao P; Ma Z; Zhang Y
Int Immunopharmacol; 2021 Sep; 98():107818. PubMed ID: 34130149
[TBL] [Abstract][Full Text] [Related]
19. Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006.
Cronin-Fenton DP; Søndergaard F; Pedersen LA; Fryzek JP; Cetin K; Acquavella J; Baron JA; Sørensen HT
Br J Cancer; 2010 Sep; 103(7):947-53. PubMed ID: 20842120
[TBL] [Abstract][Full Text] [Related]
20. Trends and Risk Factors for Venous Thromboembolism Among Hospitalized Medical Patients.
Neeman E; Liu V; Mishra P; Thai KK; Xu J; Clancy HA; Schlessinger D; Liu R
JAMA Netw Open; 2022 Nov; 5(11):e2240373. PubMed ID: 36409498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
